Pages that link to "Q36643703"
Jump to navigation
Jump to search
The following pages link to Treatment outcome for metastatic papillary renal cell carcinoma patients (Q36643703):
Displaying 35 items.
- Targeted therapies and the treatment of non-clear cell renal cell carcinoma (Q26995391) (← links)
- Extreme hypothyroidism associated with sunitinib treatment for metastatic renal cancer (Q33760079) (← links)
- A 20-year-old female with hemoptysis and high blood pressure: An unusual case of papillary renal cell carcinoma (Q33773403) (← links)
- Systemic therapy for metastatic non-clear-cell renal cell carcinoma: recent progress and future directions (Q34206531) (← links)
- Expression of angiopoietin-1, 2 and 4 and Tie-1 and 2 in gastrointestinal stromal tumor, leiomyoma and schwannoma (Q36179058) (← links)
- PD-L1 expression in papillary renal cell carcinoma (Q36249417) (← links)
- The impact of histology on clinicopathologic outcomes for patients with renal cell carcinoma and venous tumor thrombus: a matched cohort analysis (Q37010220) (← links)
- Recent advances in the systemic treatment of metastatic papillary renal cancer (Q37411186) (← links)
- Racial difference in histologic subtype of renal cell carcinoma (Q37482609) (← links)
- Role of cytoreductive nephrectomy in renal cell carcinoma. (Q37575630) (← links)
- Treatment of metastatic renal cell carcinoma. (Q37748477) (← links)
- Clinical genomics of renal epithelial tumors (Q37901793) (← links)
- Targeted therapy in renal cancer (Q37905587) (← links)
- Prolonged efficacy of mTOR inhibitors in papillary renal cell carcinoma: progression-free survival lasting for over 3 years, a case report and review of the literature (Q38071256) (← links)
- Foretinib (XL880): c-MET inhibitor with activity in papillary renal cell cancer (Q38081379) (← links)
- Pathology, therapy and prognosis of papillary renal carcinoma (Q38312048) (← links)
- A collision tumor of papillary renal cell carcinoma and oncocytoma: case report and literature review (Q38612642) (← links)
- Organ Preservation is Less Frequently Performed in Women Surgically Treated for Papillary Renal Cell Carcinoma - Results of a Comprehensive Multicenter Study (Q38627636) (← links)
- Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: a single institution retrospective study. (Q39505003) (← links)
- A HIF-regulated VHL-PTP1B-Src signaling axis identifies a therapeutic target in renal cell carcinoma (Q39532016) (← links)
- Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery. (Q41313563) (← links)
- A report of succinate dehydrogenase B deficiency associated with metastatic papillary renal cell carcinoma: successful treatment with the multi-targeted tyrosine kinase inhibitor sunitinib (Q41827281) (← links)
- The impact of histology on survival for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy (Q41881548) (← links)
- Occult infiltrating bi-ventricular papillary renal cell carcinoma metastasis found during coronary artery bypass graft surgery (Q41997465) (← links)
- Chromophobe renal cell carcinoma with prolonged response to targeted therapy: a case report (Q42158393) (← links)
- An adjusted indirect comparison of everolimus and sorafenib therapy in sunitinib-refractory metastatic renal cell carcinoma patients using repeated matched samples (Q45026359) (← links)
- A case of port-site recurrence and locoregional metastasis after laparoscopic partial nephrectomy (Q47696599) (← links)
- The role of surgery in clinical management of patients with metastatic papillary renal cell carcinoma (Q48378117) (← links)
- Brain metastasis of a papillary renal cell carcinoma, identified as type 2. (Q48526824) (← links)
- Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma – A multicentre study (Q50936722) (← links)
- Metastatic type-2 papillary renal cell carcinoma responded to interleukin-2 therapy: case report. (Q53848057) (← links)
- Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma (Q80607297) (← links)
- [Renal cell carcinoma 2008. Histopathology, molecular genetics and new therapeutic options] (Q81557185) (← links)
- Incidence and long-term prognosis of papillary renal cell carcinoma (Q82680302) (← links)
- Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinoma (Q83195458) (← links)